#Scope2

[enzo-vupico]

Why Carbon Accounting is Essential for Modern Enterprises

Carbon accounting is one of the pillars of modern business, which seeks to reconcile growth with sustainability within the context of a heightened environmental awareness and harsh regulations. It offers an orderly framework for monitoring and controlling greenhouse gas (GHG) emissions that allows companies to quantify their environmental footprint and account for global sustainability targets.

The Business Case for Carbon Accounting

Regulatory Compliance: Governments worldwide are enacting stricter emissions standards. By properly applying carbon accounting, corporations can comply with existing legal requirements and prevent potential litigation and damage to reputation.

Enhanced Decision-Making: Through the comprehension of the emission sources within Scope 1, Scope 2, and Scope 3, enterprises are in a position to adopt targeted approaches in order to minimize carbon footprint, which in turn will save costs as well as enhance operational efficiency.

Market Differentiation: Consumers and investors are more and more inclined to choose companies that have strong sustainability practices. Carbon accounting has been shown to be an expression of environmental stewardship building, enhancing brand image and competitive advantage.

Vupico SDP: Your Partner in Carbon Management

Vupico's Sustainability Data Platform (SDP) makes carbon accounting easier through the combination of enterprise data and emissions tracking automation. Key features include:

Granular Data Collection: The emissions from Track Scope 1, 2, and 3 are precisely estimated and can be fully reported and traced.

Advanced Analytics: Use AI-driven insights to pinpoint high-emitting activities and create it-in-pocket actionable strategies.

Streamlined Compliance: Develop tailored reports that comply with global regulatory requirements and meet audit requirements.

Thanks to Vupico's advanced, seamless, easy-to-use tools, companies can move from ad-hoc manual, spreadsheet-based work to automated, scalable work, which achieves both sustainability and bottom line profitability.

Take your sustainability journey steps today with Vupico SDP—digitizing intelligence for a sustainable future. Learn more at Vupico's Sustainability Data Platform.

© 2024 Vupico SDP. All rights reserved.

[tumnikkeimatome]

Scope3とは？脱炭素社会を支える温室効果ガス排出量の新基準

Scope3の基本的な概念とその重要性 Scope3とは、企業が自社の事業活動に関連して発生する温室効果ガス（GHG）のうち、直接的・間接的な排出（Scope1およびScope2）以外の、他者の活動に起因する排出量を指します。 具体的には、サプライチェーン全体で発生するGHG排出量を包括的に捉えるための指標です。 Scope3は、企業が直接管理できない範囲も含まれるため、その算定や削減は難しい一方で、全体の排出量に占める割合が非常に大きいことが特徴です。 Scope3は脱炭素社会を実現するための重要な指標として注目されています。 Scope1、Scope2との違い 温室効果ガス排出量は、以下の3つのスコープに分類されます。 Scope1: 自社内で直接的に発生する排出（例: 燃料の燃焼や工業プロセス）。 Scope2:…

[delectablywaywardbeard-blog]

Piaggio punta a tagliare le emissioni del 42% entro il 2030

Entro il 2030 Piaggio si impegna a ridurre del 42% le emissioni Scope1 e Scope2 associate alle attività produttive rispetto al 2022, stimate secondo la metodologia predisposta dallo Science-based target Iniziative1, e in linea con gli obiettivi dell’accordo di Parigi.     E’ il traguardo in linea con gli obiettivi della Unione europea, previsto dal piano di decarbonizzazione che sarà realizzato…

[icnweb]

아비바, ESG 목표 조기 달성, 직간접배출량 93% 감축

2025년 ESG 목표 15개 중 4개 달성, 직접배출량(Scope1)과 간접배출량(Scope2)에 배출량 93% 감축 아비바, ESG 목표 조기 달성 산업용 소프트웨어 글로벌 리더 아비바코리아(대표 오재진)는 2025년 직접배출량(Scope1)과 간접배출량(Scope2) 온실가스(GHG) 배출량 목표를 조기 달성했다고 밝혔다. 아비바는 이와 함께 기업들의 탈탄소화를 지원하는 소프트웨어 솔루션에 대한 투자를 늘렸다. ‘아비바 2023 지속가능성 보고서(AVEVA 2023 Sustainability Progress Report)’에 따르면, 아비바는 제품 전략, 운영, 문화 등 회사의 지속가능성 프레임워크의 세 가지 축 모두에서 높은 성과를 달성한 것으로 나타났다. 아비바는 2025년까지 달성할…

[voittoinsights]

Why an infinite game mindset is key to navigating uncertainty in business and leadership?

Table of Contents1. The Infinite Game and it’s scope2. Understanding the Infinite Game Mindset3. Navigating uncertainty in business4. Benefits of an Infinite Game Mindset in uncertain times5. Practical tips for adopting an Infinite Game Mindset6. Few examples of the Infinite Game Mindset7. Parting thoughts 1. The Infinite Game and it’s scope Experienced players never play an infinite game with…

[gunzlotzofgunz]

LES BAER 1911 BULLSEYE WAD CUTTER W/SCOPE

45 ACP; with a MATCH-DOT scope2. 4. 6. 8. MOA,

[valianttragedyllama]

Global Hemophilia Therapeutics Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

This report studies the Hemophilia Therapeutics market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Hemophilia Therapeutics in these regions, from 2017 to 2028, covering

   North America (United States, Canada and Mexico)

   Europe (Germany, France, UK, Italy, Spain and Russia, etc.)

   Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)

   South America (Brazil, Argentina, Colombia, etc.)

   Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

 Request a Sample of this report @  https://bit.ly/33ZbazZ

 Market Snapshot, By Product Type

  Hemophilia A

   Hemophilia B

   Hemophilia C

Market Snapshot, By Application

   Hospitals

   Clinics

   Ambulatory Surgical Centers

Main Market Players Analyzed in this report, including:

   Swedish Orphan Biovitrum AB.

   Pfizer, Inc.

   Novo Nordisk A/S

   Genetics Institute

   Expression Therapeutics

   Biogen Idec, Inc.

   Bayer AG

   Baxter International Inc.

   Alpha Therapeutics Corporation

The study objectives of this report are:

   To study and analyse the global Hemophilia Therapeutics market size (Million USD) by company, key regions/countries, products and application, history data from 2017 to 2021, and forecast to 2028.

   To understand industry structure of Hemophilia Therapeutics market by identifying its various subsegments.

   To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

   To identify the key global Hemophilia Therapeutics manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

   To analyze the Hemophilia Therapeutics market with respect to individual growth trends, future prospects, and their contribution to the total market.

   To project the value and volume of Hemophilia Therapeutics submarkets, with respect to key regions (along with their respective key countries).

   To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

   To strategically profile the key players and comprehensively analyze their growth strategies.

 In this study, the years considered to estimate the market size of Hemophilia Therapeutics are as follows:

   History Year: 2017-2021

   Base Year: 2021

   Estimated Year: 2022

   Forecast Year 2023 to 2028

 This report includes the estimation of market size from top-down approach by analysing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

 For the data information by region, company, type and application, 2021 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Key Stakeholders Considered in the study:

Raw material vendors

Distributors/traders/wholesalers/suppliers

Regulatory authorities, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade/Industrial associations

End-use industries

Table of Contents:-

1 Market Definition & Scope

2 Market Development Performance under COVID-19

3 3 Industrial Lift Cycle and Main Buyers Analysis

4 Market Segment: by Type

5 Market Segment: by Application

6 Marke Segment: by Region

7 North America

8 Europe

9 Asia Pacific

10 South America

11 Middle East and Africa

12 Key Participants Company Information

Company Information

       12.1.2 Swedish Orphan Biovitrum AB.

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.1.3 Swedish Orphan Biovitrum AB.

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.1.4 Swedish Orphan Biovitrum AB.

Key Development

   12.2 Pfizer, Inc.

      12.2.1 Pfizer, Inc.

Company Information

       12.2.2 Pfizer, Inc.

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.2.3 Pfizer, Inc.

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.2.4 Pfizer, Inc.

Key Development

   12.3 Novo Nordisk A/S

        12.3.1 Novo Nordisk A/S

Company Information

       12.3.2 Novo Nordisk A/S

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.3.3 Novo Nordisk A/S

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.3.4 Novo Nordisk A/S

Key Development

   12.4 Genetics Institute

      12.4.1 Genetics Institute

Company Information

       12.4.2 Genetics Institute

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.4.3 Genetics Institute

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.4.4 Genetics Institute

Key Development

   12.5 Expression Therapeutics

       12.5.1 Expression Therapeutics

Company Information

       12.5.2 Expression Therapeutics

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.5.3 Expression Therapeutics

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.5.4 Expression Therapeutics

Key Development

   12.6 Biogen Idec, Inc.

        12.6.1 Biogen Idec, Inc.

Company Information

       12.6.2 Biogen Idec, Inc.

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.6.3 Biogen Idec, Inc.

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.6.4 Biogen Idec, Inc.

Key Development

   12.7 Bayer AG

       12.7.1 Bayer AG

Company Information

       12.7.2 Bayer AG

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.7.3 Bayer AG

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.7.4 Biogen Idec, Inc.

Key Development

   12.9 Alpha Therapeutics Corporation

        12.9.1 Alpha Therapeutics Corporation

Company Information

       12.9.2 Alpha Therapeutics Corporation

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.9.3 Alpha Therapeutics Corporation

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.9.4 Alpha Therapeutics Corporation

Key Development

       12.8.1 Baxter International Inc.

Company Information

       12.8.2 Baxter International Inc.

Hemophilia Therapeutics Product Portfolio, Specification and Application

       12.8.3 Baxter International Inc.

Hemophilia Therapeutics Revenue and Gross Margin (2019-2021)

       12.8.4 Baxter International Inc.

Key Development

13 Global Hemophilia Therapeutics Market Forecast by Region by Type and by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source

To Make an Enquiry before buying this Global Hemophilia Therapeutics Market Report @ https://bit.ly/3G6wVuP

Contact Us:

Email Address: Sales@martresarch.com

Phone Number: +1-857-300-1122

Office Address: 5708, Copper Creek Court, Charlotte, North Carolina 28227, USA

[voixbiz]

「サプライチェーン排出量自動算定ソフトウェア/システム」をオンド株式会社がリリース

  人気記事：コスパ最強 年会費無料の法人カード 特集 オンド株式会社が「サプライチェーン排出量(Scope1, Scope2, Scope3)自動算定ソフトウェア/システム（ベータ版）」をリリース オンド株式会社（本社：東京都港区、代表取締役：米田 光孝）が、サプライチェーン排出量の自動算定・リアルタイムでのモニタリングが可能となる、企業の脱炭素経営に係る先進的取組の実現を支援するための「サプライチェーン排出量(Scope1, Scope2,…

[anyawinget]

The report provides a detailed assessment of the ‘Global Hair Colour Market’. This includes enabling technologies, key trends, market drivers, challenges, competition, standardization, regulatory landscape, deployment models, market size, operator case studies, opportunities, future roadmaps, value chains, ecosystem player profiles, and strategies included. The report also presents a SWOT analysis and forecast for Hair Colour investments from 2020 to 2026.

[lynleyblake]

New Gen-Eye Micro-Scope2 Includes Big, Bright 7 In. LCD Color Monitor

Inspects small 1-1/2” to 3” drain lines, toilet traps, ducts, furnaces and crawl spaces Available with USB recording drive, one-touch recording and digital 4x zoom Includes flash drive capacity indicator from Air Conditioning /fullstory/new-gen-eye-micro-scope2-includes-big-bright-7-in-lcd-color-monitor-40028790 via http://www.rssmix.com/

[chriscellman]

New Gen-Eye Micro-Scope2 Includes Big, Bright 7 In. LCD Color Monitor

Inspects small 1-1/2” to 3” drain lines, toilet traps, ducts, furnaces and crawl spaces Available with USB recording drive, one-touch recording and digital 4x zoom Includes flash drive capacity indicator from HVAC /fullstory/new-gen-eye-micro-scope2-includes-big-bright-7-in-lcd-color-monitor-40028790 via http://www.rssmix.com/

[dallasmbrownb]

General Pipe Cleaners Gen-Eye Micro-Scope2

General Pipe Cleaners’ Gen-Eye Micro-Scope2 sports a powerful new Command Module with a bigger monitor and USB port to record video inspections on flash drives.

from RSSMix.com Mix ID 8247361 https://www.pmmag.com/articles/101844-general-pipe-cleaners-gen-eye-micro-scope2 via http://www.rssmix.com/

[wait-what-no-way]

Interview with JOE GOAL

If you live anywhere in Staten Island or New York City, you have most definitely seen work by the one and only GOAL. Since 1991, GOAL has been smashing property heavy and shows no signs of stopping anytime soon. Not only has GOAL been putting work in on the streets, but he has started a few trends that have become popular over the years.

So what’s good dude? You ready to smash 2017??

2017 will be no different from the last 26 years. I’ve painted steady every year of my career and have photo albums to prove it. Over the years piecing is getting a little boring, but doing fill-ins is like busting nuts.

How many names did you go through before you chose GOAL?

Well, I went to school down the block from my house and the school had a walk over bridge that was grilled. So I always saw graffiti since first grade. At that time my best friend SW had an older brother RB. I saw him paint the bridge one day during school, and was like “I need a name.” I went into the lunchroom and I had a bag lunch with an Ecto Cooler juice box. I told my boy “I’m gonna touch the box with two fingers and those two letters gonna be my tag.” It was EC… Then RB started teaching me so I tried CE, then RE, but I liked the letters EC. So I picked 10 names from the dictionary and made my mom pick one. She chose EPIC. I stayed with that till ’95-’96 then my boy started driving me painting and I told him he needed a name also. He loves soccer so he picked GOAL. I was writing both names for two years, then the heat came on with EPIC and another old-school writer was writing it in Brooklyn so I just took GOAL and stuck with it.

The Ecto Cooler is a classic. RB, BOBBY, the train crusher? Every time I go to a layup I see at least five trains with his name on it. What kind of spots are your favorites to rock? Streets, track spots?

Nah RB is an old school Staten Island guy, not that toy crap. This guy has been piecing and doing highways and shit since the 80’s. I’ll paint anything, anytime, anywhere. My favorite thing to rock is a beautiful girl, I’m a sex-a-holic.

How many women do you think you’ve painted on?

I don’t know, my last girl asked me to paint her everyday, but I never did. As soon as she gets naked I just gotta fuck.

Growing up, what old school heads did you have the opportunity to meet growing up?

Well, I’m from Staten so there are a lot of people the other boroughs aren’t familiar with. These were the guys I looked up to and learned from. Such as, SCOPE2, MARS, ECHO, VERS, TEO, LEV, SIGN, FADE, but I did leave Staten Island and met a lot of people. Ones that stick out to me are guys like CAP MPC, TRACY 168, HEKTAD, COPE2, JUST WF, NOE, TYKE TFO. I always show respect to the guys that paved the way for me. Now days these new kids have no respect and they suck, no style.

And that’s a fact. A lot of cats are ready to go out and paint, but don’t know any history. What was one of the first spots you busted a nut your first time hitting?

Wow, a lot of shit. In the late 90’s, I went all city. I drove more than public transportation. So I was smashing highways like the BQE was that dope shit, roofs, all of the major avenues. I remember I linked up with JUST WF and did a few spots in the Bronx and I think I went over somebody. Soon after that I linked up with JEE and since they told me to meet them in the Bronx I trooped out there and met COPE, REMO, SPEK BTC R.I.P. and we painted the 2 and 5 lines till noon the next day. There were fill-ins on everything. I kept going to the Bronx with the WF crew and BTC crew killing shit, but that came to a halt when vandal squad caught up with me.

Oh shit, how long did they have you bagged for?

That was a long time ago and I only got community service for that case. I have been to jail for graffiti and it sucked. Sorry, but I really don’t want to talk about that part of graffiti. I feel underrated and hated on in the graffiti community. The hate and jealousy is real. If I was a bum broke toy I would be mad too. I just wish I got credit for some trends I started, like the whole collaborative fill-in collages on canvas in the 90’s. I used to always have a canvas on me and had good writers do their stamp fill-in for me. The next thing you know people realized it was a good idea. Better than a black book because you close the book and you cant see the work; the canvas is hanging.

No worries, totally understandable. How often do you like rocking canvases?

24 hours, now 20 years later every writer does it. I do pieces on canvas once a month. I do a fill-in on canvas everyday. You could ask writers like KECH REC, HEILS MIA, KEVS MIA, SERF, MINT, if I’m telling the truth. Just like SERF and MINT started the whole vinyl sticker fill-in cut outs and never get credit. I’ve seen a lot of writers come and go; jock and bite styles, and I’m still here doing my thing.

I believe you. You grew up in a different era with graffiti. Things are a lot different now then what they used to be. How many times have you ever caught somebody trying to bite off you or even your crew’s style?

I don’t mind people biting or using my ideas as influence, just show me love and respect. When I was a kid I always looked at RB, SCOPE2, MARS TNI and others. I bit and learned from them, and to this day I still show them love and respect. It’s hard to being a well-rounded graffiti artist. Learning all the letters, throwups, pieces, tags, block letters, how to bomb consistent, picking spots connecting with others, and doing piece walls. Now I think the computer is another element you have to learn to be a graffiti artist. Even the sticker game is part of it. If you’re a king you have to do it all and don’t stop doing it. There’s guys that pop up every five years and think they’re the shit. Take a hike, I’m out here 12 months a year risking it all for this sport.

What other trends have you started?

Another trend I started was when I started writing JOE GOAL. I remember seeing one old-school guy write his name before his tag, but I went crazy with it. Next thing you know anybody with the name “Joe” was writing it in front of their tag. Then the entire New York side, and even some guy from Jersey shows the kid no love.

Where else outside of New York have you had the opportunity to paint?

I’ve been all over the United States; I’ve connected with some great people. LA was fun. I have graffiti family in Baltimore. My man CASPA HITS RTH… RTH crew is worldwide and I’m a huge part of the crew so I can go anywhere and have a place to stay with a tour guide. I’ve been to Europe, which was fun. I painted non-stop everyday. Right now there’s a dope scene in New Jersey. A lot of good writers are putting in work, and I like being a part of it. My young bull DRANE RTH helps me kill shit out there. If you do your homework on RTH crew you will see how big the gang is.

That’s dope. Mad respect. What’s the highest you’ll go to hit something? Anything like highways signs?

The moon… I’ve done it all man and I’ll keep doing it. You gotta respect the art youngsters. Like in hockey you might be able to fight, but if you’ve never scored a goal you suck man. So in graff you can be a fake, immature, tough guy and try to impress people or you can act like a grown man and show your skills.

What kind of rush do you get when you hit heaven spots?

I used to get super high on some crazy drugs, so that shit doesn’t really do much for me. On a bomb after my first fill-in for the night I feel open, like I have permission to kill shit no fear, but the first fill-in always has me shook.

What type of freak things have you seen throughout your graffiti career?

Just some chases and bullshit. One time I was filming for my movie called “A Day in the Life” and I was rocking my fill-in on the street. A big silver stomper. As I’m spraying, a red laser beam is following my hand on the wall. The whole time I thought it was the camera. When I finished the fill I asked the cameraman about the red light and he said it wasn’t him. So I said, “Let’s hurry up, outline, and be out.” As I started to outline the red light came back. This time I followed it to a house across the street and got shook. The next thing I know there’s mad cops so I told the cameraman “Yo, go one way and I’ll go the other.” As the cops came down the wrong way on the street, I walk up to them and they ask to see my hands and my arm was covered in silver. So I started to jet, and made it three blocks. They hit me with the car, and beat me bad. I needed staples in my head and had a broken nose, but two weeks later I filmed for the movie. You can cop it online or go to it on Instagram.

What’s the biggest piece you’ve done to this day?

That one’s in Staten Island, by the Wu-Tang projects.

Anyone you want to give a shout out to?

Shout out to OUCH MIA, Rest In Peace. Shout out to GN RTH RIP. Shout out to Michelle Emz for being so hot. Shout out to DG NWC, SPEK BTC, ODB Wu-Tang, Erik Garner, fuck all cops. Shout out to the homeless bum that rapped MAP. Shout out to all the hookers and sluts sucking dicks. Fuck all graffiti writers, you all suck and jock each other like homos. Guys who like guys go to other art shows for an autograph. I’m the greatest NYC kid in the game. No breaks, come suck a fart out of my ass.

[twobeemag]

SES: Full Year 2016 Results: A Year of Acceleration and Building Differentiated Capabilities

SES: Full Year 2016 Results: A Year of Acceleration and Building Differentiated Capabilities

LUXEMBOURG–(BUSINESS WIRE)–SES S.A. (Euronext Paris:SESG) (LuxX:SESG) announced financial results for the year ended 31 December 2016. Strong business fundamentals delivering solid financial performance Reported revenue of EUR 2,068.8 million, up 2.7% over prior year (+2.4% at constant FX1) Revenue 2.7% lower at same scope2 and constant FX Group EBITDA margin of 70.2% (2015: 74.2%); same…

[leedsomics]

High-throughput single-cell proteomics quantifies the emergence of macrophage heterogeneity

The fate and physiology of individual cells are controlled by networks of proteins. Yet, our ability to quantitatively analyze protein networks in single cells has remained limited. To overcome this barrier, we developed SCoPE2. It integrates concepts from Single-Cell ProtEomics by Mass Spectrometry (SCoPE-MS) with automated and miniaturized sample preparation, substantially lowering cost and hands-on time. SCoPE2 uses data-driven analytics to optimize instrument parameters for sampling more ion copies per protein, thus supporting quantification with improved count statistics. These advances enabled us to analyze the emergence of cellular heterogeneity as homogeneous monocytes differentiated into macrophage-like cells in the absence of polarizing cytokines. We used SCoPE2 to quantify over 2,000 proteins in 356 single monocytes and macrophages in about 85 hours of instrument time, and the quantified proteins allowed us to discern single cells by cell type. Furthermore, the data uncovered a continuous gradient of proteome states for the macrophage-like cells, suggesting that macrophage heterogeneity may emerge even in the absence of polarizing cytokines. Our methodology lays the foundation for quantitative analysis of protein networks at single-cell resolution. http://dlvr.it/R6L0R8

[streetartsf]

In support of Je Suis Charlie.

Scope 2.

Photography by Larry Jones.

Cypress Alley @ 24th Street in San Francisco, Ca